Cooperative Roles of SDF-1α and EGF Gradients on Tumor Cell Migration Revealed by a Robust 3D Microfluidic Model

Chemokine-mediated directed tumor cell migration within a three dimensional (3D) matrix, or chemoinvasion, is an important early step in cancer metastasis. Despite its clinical importance, it is largely unknown how cytokine and growth factor gradients within the tumor microenvironment regulate chemoinvasion. We studied tumor cell chemoinvasion in well-defined and stable chemical gradients using a robust 3D microfluidic model. We used CXCL12 (also known as SDF-1α) and epidermal growth factor (EGF), two well-known extracellular signaling molecules that co-exist in the tumor microenvironment (e.g. lymph nodes or intravasation sites), and a malignant breast tumor cell line, MDA-MB-231, embedded in type I collagen. When subjected to SDF-1α gradients alone, MDA-MB-231 cells migrated up the gradient, and the measured chemosensitivity (defined as the average cell velocity along the direction of the gradient) followed the ligand – receptor (SDF-1α – CXCR4) binding kinetics. On the other hand, when subjected to EGF gradients alone, tumor cells increased their overall motility, but without statistically significant chemotactic (directed) migration, in contrast to previous reports using 2D chemotaxis assays. Interestingly, we found that the chemoinvasive behavior to SDF-1α gradients was abrogated or even reversed in the presence of uniform concentrations of EGF; however, the presence of SDF-1α and EGF together modulated tumor cell motility cooperatively. These findings demonstrate the capabilities of our microfluidic model in re-creating complex microenvironments for cells, and the importance of cooperative roles of multiple cytokine and growth factor gradients in regulating cell migration in 3D environments.

[1]  Douglas A Lauffenburger,et al.  Quantitative analysis of gradient sensing: towards building predictive models of chemotaxis in cancer. , 2012, Current opinion in cell biology.

[2]  L. Lebrun,et al.  Diffusion of sucrose and dextran through agar gel membranes. , 1993, Enzyme and microbial technology.

[3]  P. Gao,et al.  Protein kinase C zeta is required for epidermal growth factor-induced chemotaxis of human breast cancer cells. , 2005, Cancer research.

[4]  Mingming Wu,et al.  Dendritic cell chemotaxis in 3D under defined chemokine gradients reveals differential response to ligands CCL21 and CCL19 , 2011, Proceedings of the National Academy of Sciences.

[5]  Jing Wu,et al.  Screening of a PKC ζ-specific kinase inhibitor PKCzI257.3 which inhibits EGF-induced breast cancer cell chemotaxis , 2010, Investigational New Drugs.

[6]  J. Schlessinger The epidermal growth factor receptor as a multifunctional allosteric protein. , 1988, Biochemistry.

[7]  L. Bonassar,et al.  Dense type I collagen matrices that support cellular remodeling and microfabrication for studies of tumor angiogenesis and vasculogenesis in vitro. , 2010, Biomaterials.

[8]  I. Macdonald,et al.  Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.

[9]  M. Sixt,et al.  Rapid leukocyte migration by integrin-independent flowing and squeezing , 2008, Nature.

[10]  Jian Zhang,et al.  CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression , 2010, Cancer and Metastasis Reviews.

[11]  J. Schlessinger,et al.  Allosteric regulation of the epidermal growth factor receptor kinase , 1986, The Journal of cell biology.

[12]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[13]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[14]  N. Jeon,et al.  Biological applications of microfluidic gradient devices. , 2010, Integrative biology : quantitative biosciences from nano to macro.

[15]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[16]  James Castracane,et al.  A new chemotaxis device for cell migration studies. , 2010, Integrative biology : quantitative biosciences from nano to macro.

[17]  Beum Jun Kim,et al.  Microfluidics for Mammalian Cell Chemotaxis , 2011, Annals of Biomedical Engineering.

[18]  Jeffrey Wyckoff,et al.  Epidermal growth factor receptor overexpression results in increased tumor cell motility in vivo coordinately with enhanced intravasation and metastasis. , 2006, Cancer research.

[19]  J. Pollard,et al.  Microenvironmental regulation of metastasis , 2009, Nature Reviews Cancer.

[20]  J. Zavadil,et al.  Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profiling. , 2002, Cancer research.

[21]  R. Bonavia,et al.  Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation. , 2005, Experimental cell research.

[22]  Stephanie I. Fraley,et al.  A distinctive role for focal adhesion proteins in three-dimensional cell motility , 2010, Nature Cell Biology.

[23]  A. Agarwal,et al.  Epidermal growth factor promotes MDA-MB-231 breast cancer cell migration through a phosphatidylinositol 3'-kinase and phospholipase C-dependent mechanism. , 1999, Cancer research.

[24]  John S. Condeelis,et al.  Chemotaxis in cancer , 2011, Nature Reviews Cancer.

[25]  B. Vanhaesebroeck,et al.  Regulation of breast cancer cell chemotaxis by the phosphoinositide 3-kinase p110delta. , 2003, Cancer research.

[26]  Patrick Gizzi,et al.  Small Neutralizing Molecules to Inhibit Actions of the Chemokine CXCL12* , 2008, Journal of Biological Chemistry.

[27]  H. El-Samad,et al.  Bound attractant at the leading vs. the trailing edge determines chemotactic prowess , 2007, Proceedings of the National Academy of Sciences.

[28]  David J Beebe,et al.  A platform for assessing chemotactic migration within a spatiotemporally defined 3D microenvironment. , 2008, Lab on a chip.

[29]  Mingming Wu,et al.  An agarose-based microfluidic platform with a gradient buffer for 3D chemotaxis studies , 2009, Biomedical microdevices.

[30]  J. Segall,et al.  Intravital imaging of cell movement in tumours , 2003, Nature Reviews Cancer.

[31]  B. Mosadegh,et al.  Epidermal growth factor promotes breast cancer cell chemotaxis in CXCL12 gradients , 2008, Biotechnology and bioengineering.

[32]  Mingming Wu,et al.  A hydrogel-based microfluidic device for the studies of directed cell migration. , 2007, Lab on a chip.

[33]  Peter Friedl,et al.  Compensation mechanism in tumor cell migration , 2003, The Journal of cell biology.

[34]  F. Balkwill The significance of cancer cell expression of the chemokine receptor CXCR4. , 2004, Seminars in cancer biology.

[35]  Zigmond Sh Ability of polymorphonuclear leukocytes to orient in gradients of chemotactic factors. , 1977 .

[36]  P. Steeg Tumor metastasis: mechanistic insights and clinical challenges , 2006, Nature Medicine.

[37]  Qian Wang,et al.  Control of epidermal growth factor receptor endocytosis by receptor dimerization, rather than receptor kinase activation , 2005, EMBO reports.

[38]  William C Hines,et al.  Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression , 2011, Nature Medicine.

[39]  S. Zigmond,et al.  ABILITY OF POLYMORPHONUCLEAR LEUKOCYTES TO ORIENT IN GRADIENTS OF CHEMOTACTIC FACTORS , 2003 .

[40]  Ulrike Haessler,et al.  Migration dynamics of breast cancer cells in a tunable 3D interstitial flow chamber. , 2012, Integrative biology : quantitative biosciences from nano to macro.

[41]  D. Lauffenburger,et al.  Autocrine epidermal growth factor signaling stimulates directionally persistent mammary epithelial cell migration , 2001, The Journal of cell biology.

[42]  Francis Lin,et al.  Differential effects of EGF gradient profiles on MDA-MB-231 breast cancer cell chemotaxis. , 2004, Experimental cell research.

[43]  R. Bonavia,et al.  Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation. , 2005, Experimental cell research.

[44]  Melody A Swartz,et al.  Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling. , 2007, Cancer cell.

[45]  John Condeelis,et al.  Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis , 2006, Cell.

[46]  Erik Sahai,et al.  Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. , 2005, Cancer research.

[47]  J. Galzi,et al.  Optimal Inhibition of X4 HIV Isolates by the CXC Chemokine Stromal Cell-derived Factor 1α Requires Interaction with Cell Surface Heparan Sulfate Proteoglycans* , 2001, The Journal of Biological Chemistry.

[48]  Jeffrey Wyckoff,et al.  Description and characterization of a chamber for viewing and quantifying cancer cell chemotaxis. , 2005, Cell motility and the cytoskeleton.

[49]  Noo Li Jeon,et al.  Microfluidic chambers for cell migration and neuroscience research. , 2006, Methods in molecular biology.

[50]  M. Poo,et al.  Endothelial cell polarization and chemotaxis in a microfluidic device. , 2008, Lab on a chip.

[51]  S. Takayama,et al.  Receptor differential activation and cooperativity better explain cellular preference for different chemoattractant gradient shapes in an EGFR system. , 2011, Integrative biology : quantitative biosciences from nano to macro.